India Acne Therapeutics Market Analysis Report 2022 to 2030

India Acne Therapeutics Market Analysis

$ 3999

India's acne therapeutics market is expected to witness growth from $182 Mn in 2022 to $383 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-30. due to the increasing demand for combination therapies and associated results for acne treatment. The market is segmented by treatment, route of administration, age group, and by distribution channel. Cipla Pharmaceuticals, Glenmark Pharmaceuticals, and Teva Pharmaceuticals are some of the leading companies in India's acne therapeutics market.

ID: IN10INPH027 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Parul Choudhary

Buy Now

India Acne Therapeutics Market Executive Analysis

India's acne therapeutics market is expected to witness growth from $182 Mn in 2022 to $383 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-30. A staggering $10.75 Bn has been set aside for health expenditures in the Union Budget 2023, an increase of $0.28 Bn or 2.71 % from $10.47 Bn in FY23. The Ministry of Health's Budget Estimates for 2022–23 were originally set at $10.42 Bn but were later revised to $9.57 Bn for the same time. This year, an estimated $10.78 Bn will be spent. Last year, healthcare spending made up around 2.2 % of the Budget; this year, it is only 1.97 %.

In India, more than 85% of teenagers and two-thirds of people who are 18 years of age and older suffer from acne vulgaris. It is a pilosebaceous unit chronic inflammatory illness characterized by seborrhoea, papules, pustules, open and closed comedones, nodules, pseudocysts, and scarring in more severe cases. Propionibacterium acne and sebum are among the many factors that contribute to its multifactorial etiopathogenesis. Males in India experience acne vulgaris more frequently and severely than females. Topical, oral, and surgical therapy are all available for the treatment of acne. Topical therapies can be used to treat patients with mild acne, but systemic treatment is necessary for those with moderate to severe acne. The three primary systemic medications for acne are oral antibiotic therapy, hormone medicines, and isotretinoin. Mesotherapy, or micro-needling with a derma-roller, is a recent innovation in India that, when combined with the instillation of hyaluronic acid serum, is producing encouraging results for the efficient treatment of unappealing acne scars. And then the i-Pixel Er: YAG laser is used to cure stubborn acne scars. Recently, under the brand name MINYM, Glenmark Pharmaceuticals has introduced the first topical Minocycline 4% Gel for the treatment of moderate to severe acne in India.

India Acne Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

In India, the market is being driven by an increase in the use of combination therapies for acne treatment (such as benzoyl peroxide + antibiotics) and the demand for faster results. Additionally, the extreme pollution in some areas, like Delhi, is causing a surge in acne among the local population, which is further driving the India acne therapeutics market.

Market Restraints

The India acne therapeutics market is being restricted by acne treatment medications' long-term effectiveness and undesirable side effects.

Competitive Landscape

Key Players

Sun Pharma (IND)
Hegde and Hegde Pharma (IND)
Mankind Pharmaceuticals (IND)
Cipla Pharmaceuticals (IND)
Glenmark Pharmaceuticals (IND)
Teva Pharmaceuticals
Candela
Almirall
Galderma

Healthcare Policies and Regulatory Landscape

Acne treatment coverage is part of the benefits package for government-sponsored insurance programs including the Central Government Health Scheme (CGHS) and the Employees State Insurance Corporation (ESIC). Depending on the specific policy, private insurance coverage for acne treatments can range from minimal coverage to more extensive coverage that encompasses both oral and topical drugs as well as procedures like chemical peels and light therapy. The manufacture of cosmetics is governed by a system of inspection and licensing by the State Licensing Authorities appointed by the respective State Governments of India, while the import of cosmetics is governed by a system of registration by the Central Licensing Authority appointed by the Central Government, in accordance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules made in Central Drugs Standard Control Organization (CDSCO). In accordance with the terms of the 1940 Drugs and Cosmetics Act, the Drugs Controller General (India) serves as the Central Licensing Authority, granting the Import Registration Certificate and controlling the import of cosmetics into India.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Acne Therapeutics Market Segmentation

By Treatment (Revenue, USD Billion):

Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents
- Anti-Inflammatory
- Other Agents
- Other Treatments

By Route of Administration (Revenue, USD Billion):

Oral
Topical
Injectable

By Age Group (Revenue, USD Billion):

10 to 17
18 to 44
45 to 64
65 and above

By Distribution Channel (Revenue, USD Billion):

Hospital Pharmacies
Retail and Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.